IRIS
IEZZI, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.681
EU - Europa 3.978
AS - Asia 2.770
SA - Sud America 328
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 7
Totale 11.810
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.635
SG - Singapore 1.064
CN - Cina 827
IT - Italia 771
IE - Irlanda 708
UA - Ucraina 604
SE - Svezia 483
TR - Turchia 471
GB - Regno Unito 386
DE - Germania 322
BR - Brasile 300
FR - Francia 277
IN - India 258
FI - Finlandia 151
RU - Federazione Russa 109
NL - Olanda 43
CZ - Repubblica Ceca 39
VN - Vietnam 38
HK - Hong Kong 32
BE - Belgio 28
CA - Canada 22
AT - Austria 21
IQ - Iraq 13
IR - Iran 13
EU - Europa 12
BD - Bangladesh 11
ZA - Sudafrica 11
MX - Messico 9
PL - Polonia 9
GR - Grecia 7
IL - Israele 7
MA - Marocco 7
VE - Venezuela 7
AR - Argentina 6
AU - Australia 5
BZ - Belize 4
CL - Cile 4
PK - Pakistan 4
PT - Portogallo 4
RO - Romania 4
SA - Arabia Saudita 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
ES - Italia 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
OM - Oman 3
PY - Paraguay 3
UZ - Uzbekistan 3
AO - Angola 2
AZ - Azerbaigian 2
CR - Costa Rica 2
EC - Ecuador 2
HN - Honduras 2
JM - Giamaica 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
ID - Indonesia 1
LB - Libano 1
LK - Sri Lanka 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
UY - Uruguay 1
Totale 11.810
Salva come PNG Salva come JPEG
Città #
Chandler 896
Singapore 766
Jacksonville 704
Dublin 698
Princeton 300
Southend 286
Dearborn 233
Izmir 225
Nanjing 187
Beijing 166
Ann Arbor 155
Ashburn 155
Altamura 134
Wilmington 134
Santa Clara 128
Chieti 121
The Dalles 112
Cambridge 111
New York 107
Boardman 98
Pescara 95
Tongling 78
Nanchang 63
Munich 62
Los Angeles 51
Woodbridge 50
Helsinki 35
Hebei 34
Grevenbroich 33
Dong Ket 31
Hong Kong 31
Tianjin 30
Washington 30
Shenyang 29
Brno 28
Rome 28
Nuremberg 26
Kunming 24
Brussels 23
Norwalk 23
São Paulo 23
Seattle 22
Changsha 21
Ancona 20
Frankfurt am Main 19
Jiaxing 18
London 18
Turku 18
Milan 17
Castignano 16
Chicago 16
Hangzhou 16
Jinan 16
San Mateo 16
Augusta 15
Brooklyn 15
Amsterdam 14
Orange 14
Falls Church 13
Houston 13
Rio de Janeiro 13
Vienna 13
Camerino 12
Pune 12
Guangzhou 11
Leawood 11
Ascoli Piceno 10
Toronto 10
Ardabil 9
Bologna 9
Changchun 9
Hefei 9
Lanzhou 9
Napoli 9
Verona 9
Belo Horizonte 7
Collecorvino 7
Columbus 7
Johannesburg 7
Olomouc 7
Senigallia 7
Zhengzhou 7
Baghdad 6
Boston 6
Düsseldorf 6
Guarulhos 6
Romola 6
Rouen 6
Saint-Saens 6
San Francisco 6
Stockholm 6
Taizhou 6
Warsaw 6
Bari 5
Charlotte 5
Curitiba 5
Istanbul 5
Lappeenranta 5
Monmouth Junction 5
San Giovanni 5
Totale 7.165
Salva come PNG Salva come JPEG
Nome #
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 145
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 144
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 134
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 133
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 125
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 118
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 117
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 115
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 114
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 113
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 111
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 110
L’allergoide monomerico agisce anche sul GALT 108
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 106
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 105
Anti-Thyroid Effect of Resveratrol 105
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 104
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 103
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 102
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 102
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 102
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 102
Effects of chronic hypoxia and cobalt on macroprotein pattern in the rabbit carotid body and superior cervical ganglion: preliminary observations. 101
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 101
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 100
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 100
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 99
Resveratrol has anti-thyroid effects both in vitro and in vivo 99
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 99
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer. 98
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 98
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 98
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 98
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 97
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 97
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 97
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer 97
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 96
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 96
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 96
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 96
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 95
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 95
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 94
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 94
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 93
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. 93
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 93
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 93
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 92
EFFECTS OF HYPERBARIC OXYGEN EXPOSURE ON MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS 91
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 90
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 89
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 89
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 88
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 88
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 88
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 87
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 87
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 87
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 87
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 87
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. 86
Neutrophils in anti-cancer immunological strategies: old players in new games 86
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 86
Antimetastatic activity of a preventive cancer vaccine. 85
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 85
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 85
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 84
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 83
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 82
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 81
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 81
Inhibition of the Phosphatidylinositol 3-kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects. 81
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. 80
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 80
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 80
Stem Cell Emergence After HBO In Volunteers 80
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 80
Expression of CREB in Primary Pterygium and Correlation with Cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. 80
Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. 80
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 79
Effect of acute and chronic cobalt administration on carotid body chemoreceptors responses. 79
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDAapproved compounds 79
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma 79
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment 79
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 79
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 78
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 77
p130Cas is an essential transducer element in ErbB2 transformation. 77
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 77
Phospholipase Cgamma1 is required for metastasis development and progression 76
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 75
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 75
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 75
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 75
Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice. 74
Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma. 74
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 74
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 74
Totale 9.301
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021932 135 17 150 12 88 165 27 10 58 115 90 65
2021/2022708 14 14 14 120 53 12 26 60 55 50 83 207
2022/20232.468 184 362 156 280 272 471 127 168 285 32 63 68
2023/20241.158 78 54 68 51 61 346 270 66 14 28 13 109
2024/20252.929 173 490 388 102 94 136 205 194 294 130 325 398
2025/2026222 222 0 0 0 0 0 0 0 0 0 0 0
Totale 12.365